Tag: Heart Bypass
Open Heart Surgery Beats Stents for Multivessel Disease
Findings reinforce need for team approach to treatment decisions for heart conditions
Death at 10 Years Similar With Bilateral-, Single-Artery CABG
No difference seen in rate of death from any cause at 10 years in intention-to-treat analysis
AHA: Lasting Benefit for CABG in Diabetes, Multivessel Disease
Lower all-cause mortality in CABG group versus PCI-DES group after median follow-up of 7.5 years
Improved Outcomes With Public Reporting of CABG Data
Decrease in observed and expected mortality rates, risk factor rates from 2002 to 2014 in Massachusetts
Lower Thromboembolic Risk With New A-Fib After CABG Versus NVAF
Thromboembolic risk lower for postoperative atrial fibrillation s/p CABG versus nonvalvular a-fib
Anticoagulation Guidance Issued for Cardiopulmonary Bypass
Recommendations for heparin dosing and monitoring, contraindications and alternatives, reversal
CABG May Be Best Method to Revascularize in Diabetes
Cardiac, cerebrovascular events lower in patients with multivessel coronary artery disease
CABG May Be Best for Multivessel Revascularization in T1DM
Increased risks of coronary heart disease mortality, MI, repeat revascularization with PCI
On-Pump CABG Leads to Higher Rates of Five-Year Survival
Study compared coronary-artery bypass grafting surgery, with/without cardiopulmonary bypass
Multiple Dosing Mitigates ASA Hyporesponsiveness After CABG
Multiple dosing more effective than ASA 81 or 325 mg once-daily for suppressing serum TXB2 formation
